China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received marketing approval for its Vericor peripheral support catheter from the Thailand Food and Drug Administration. This development marks a significant step for the company as it expands the reach of its medical devices in the Southeast Asian market.
Vericor’s Role in Peripheral Vascular Treatments
Vericor is a peripheral support catheter designed to improve the peripheral vascular pathway, playing a crucial role in vascular interventions. When used in conjunction with a guide wire, Vericor can assist in recanalizing chronic total occlusions (CTO), above-the-knee (ATK), and below-the-knee (BTK) lesions. Its application can reduce the surgical difficulty associated with complex lesions and BTK lesions, potentially improving patient outcomes and procedural efficiency.
Implications of the Approval
The approval of Vericor by the Thailand FDA not only signifies regulatory validation but also opens up new opportunities for Acotec Scientific Holdings Ltd in the Thai medical device market. This approval is expected to enhance the company’s footprint in the peripheral vascular intervention space and contribute to its growth strategy in the region.-Fineline Info & Tech
